Objective. Cytosolic DNA sensors detect microbial DNA and promote type I interferon (IFN) and proinflammatory cytokine production through the adaptor stimulator of IFN genes (STING) to resolve infection. Endogenous DNA also engages the STING pathway, contributing to autoimmune disease. This study sought to identify the role of STING in regulating bone formation and to define the bone phenotype and its pathophysiologic mechanisms in arthritic mice double deficient in DNase II and IFN-a/b/v receptor (IFNAR) (DNase II 2/2 / IFNAR 2/2 double-knockout [DKO] mice) compared with controls.
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Objective. Cytosolic DNA sensors detect microbial DNA and promote type I interferon (IFN) and proinflammatory cytokine production through the adaptor stimulator of IFN genes (STING) to resolve infection. Endogenous DNA also engages the STING pathway, contributing to autoimmune disease. This study sought to identify the role of STING in regulating bone formation and to define the bone phenotype and its pathophysiologic mechanisms in arthritic mice double deficient in DNase II and IFN-a/b/v receptor (IFNAR) (DNase II 2/2 / IFNAR 2/2 double-knockout [DKO] mice) compared with controls.
Methods. Bone parameters were evaluated by microcomputed tomography and histomorphometry in DKO mice in comparison with mice triple deficient in STING, DNase II, and IFNAR and control mice. Cell culture techniques were employed to determine the parameters of osteoclast and osteoblast differentiation and function. NanoString and Affymetrix array analyses were performed to identify factors promoting ectopic bone formation.
Results. Despite the expression of proinflammatory cytokines that would be expected to induce bone loss in the skeleton of DKO mice, the results, paradoxically, demonstrated an accumulation of bone in the long bones and spleens, sites of erythropoiesis and robust DNA accrual. In addition, factors promoting osteoblast recruitment and function were induced. Deficiency of STING significantly inhibited bone accrual.
Conclusion. These data reveal a novel role for cytosolic DNA sensor pathways in bone in the setting of autoimmune disease. The results demonstrate the requirement of an intact STING pathway for bone formation in this model, a finding that may have relevance to autoimmune diseases in which DNA plays a pathogenic role. Identification of pathways linking innate immunity and bone could reveal novel targets for the treatment of bone abnormalities in human autoimmune diseases.
Innate immune pattern recognition receptors, including cytosolic DNA sensors, detect nucleic acids from microbial organisms and orchestrate immune events and the production of cytokines to clear infection (1) . Upon detection of DNA, cytosolic sensors, including, among others, cyclic GMP-AMP cyclase and interferon (IFN)-inducible protein 16 (IFI-16)/IFI-204, signal through the adaptor stimulator of IFN genes (STING), leading to the nuclear translocation of IFN regulatory factor 3 and NFkB and to the production of type I IFNs and proinflammatory cytokines (2) .
Endogenous DNA derived from stressed or dying cells can activate these same cytosolic DNA sensing pathways, contributing to autoimmune disease (3) (4) (5) . Inactivation of intracellular DNases in animal models leads to host DNA accrual, resulting in autoinflammatory and autoimmune disease. For example, deficiency of the endonuclease DNase III (TREX1) in mice results in systemic inflammation and myocarditis due to accrual of cytosolic DNA and STING-dependent production of type I IFNs and proinflammatory cytokines by nonhematopoietic cells (6, 7) . In humans, loss-of-function mutations in TREX1 are associated with Aicardi-Goutières syndrome, chilblain lupus, and systemic lupus erythematosus (SLE) (8) (9) (10) (11) (12) (13) .
Further evidence of a role for the STING pathway in autoimmunity is provided by the discovery of human gain-offunction mutations in Sting (Tmem173), leading to constitutive activation of STING in fibroblasts and endothelial cells, which results in the clinical syndrome of STINGassociated vasculopathy with onset of infancy (SAVI). Patients with SAVI develop vasculopathy, skin lesions, pulmonary fibrosis, and arthritis (14) .
Finally, endogenous DNA accrual from inactivation of DNase II, a lysosomal nuclease that degrades doublestranded DNA (dsDNA), is also associated with autoimmunity. In humans, single-nucleotide polymorphisms in the promoter region of the DNase II gene, which results in reduced DNase II activity, are associated with the development of rheumatoid arthritis (15) . In mice deficient in DNase II, DNA accumulates in phagolysosomes and, secondarily, in the cytosol of multiple cell types, including macrophages and fibroblasts (16) . Macrophages also engulf nuclei from apoptotic cells, leading to DNA accrual and the production of tumor necrosis factor (TNF), interleukin-1b (IL-1b), and IL-6, as well as type I IFNs. Excessive type I IFN production leads to anemia-driven embryonic mortality, from which these mice are rescued when the gene for the type I IFN-a/b/v receptor (IFNAR) is also deleted. heterozygous (Het) control mice (17) . This arthritis is entirely abrogated in the setting of STING deficiency (4, 18) , and is significantly attenuated by loss of the inflammasome-promoting cytosolic DNA sensor AIM2 (absent in melanoma 2) (4, 5) . DKO mice also develop clinical manifestations of SLE through pathways that are independent of STING but rely on Unc93B1, an adaptor protein required for endosomal Toll-like receptor (TLR) activity (4, 19) .
In the setting of inflammatory arthritis, proinflammatory cytokines contribute to both articular and systemic bone loss due to enhanced osteoclast-mediated bone resorption and inhibition of osteoblast-mediated bone formation (20) (21) (22) (23) . In DKO mice, we therefore anticipated the development of osteoporosis arising from systemic production of TNF and IL-1b (17, 24) , which should induce osteoclastogenesis and bone resorption (25) (26) (27) (28) . In addition, type I IFNs inhibit osteoclast differentiation, and IFNAR-deficient mice demonstrate enhanced osteoclastogenesis and lose bone systemically (29) . However, in the setting of DNA accrual in the DKO model of arthritis, we found an unexpected and dramatic enhancement of bone formation in the long bones and spleens, which are 2 sites of erythropoiesis and local DNA accumulation (17) . Furthermore, STING deficiency abrogated bone accrual, revealing a potential role for this cytosolic DNA sensor pathway in bone. Collectively, these data may provide insights into human bone disorders occurring in the context of autoimmunity.
MATERIALS AND METHODS
Mouse strains. C57BL/6 DNase II 1/2 mouse embryos were provided by Dr. S. Nagata (Osaka Medical School) through the RIKEN Institute, and mice were crossed to C57BL/6 IFNAR 2/2 mice to produce DNase II Histopathologic analysis. The hind limbs of all mice were fixed in 4% paraformaldehyde, decalcified in 15% EDTA, embedded in paraffin, and sectioned at 5 mm. Sections were deparaffinized and stained with either hematoxylin and eosin (H&E) or tartrate-resistant acid phosphatase (TRAP) (30) . The spleens were fixed, embedded in methylmethacrylate, sectioned, and then stained with H&E, TRAP, von Kossa's stain, or Goldner's trichrome.
Micro-computed tomography (micro-CT). Fixed bones were imaged using a Scanco Medical mCT 40 at 70 kVp and 114 mA. Analyses included micro-CT evaluation of trabecular bone within the entire femur from the proximal to distal growth plates, a 0.5-mm section in the central diaphysis of cortical bone, and trabecular bone within the rostral to caudal growth plates of the L3 lumbar vertebrae. Segmentation parameters included the following values: 0.8G sigma, 1.0G support, and a threshold of 220-1,000 Hounsfield units.
Static histomorphometric analysis. Femurs were fixed in 10% neutral buffered formalin and embedded in methylmethacrylate (22) . The proximal femoral metaphysis was sectioned longitudinally (5 mm), mounted to slides with nonfluorescent medium, and stained with McNeal's trichrome (for osteoid parameters) and TRAP (for osteoclasts). A region of interest ;4 mm 2 within the secondary spongiosa (;0.5 mm distal to the growth plate) was defined, and osteoid area, bone area, bone surface, osteoblast surface (ObS), and osteoclast surface (OcS) were measured using a Nikon Optiphot 2 microscope interfaced to a semiautomatic analysis system (Bioquant OSTEO 7.20.10; Bioquant Image Analysis). Measurements were performed on 2 sections/sample (separated by ;25 mm) and summed prior to normalization to obtain a single measure per sample. All parameters were measured and defined in accordance with American Society for Bone and Mineral Research standards (31) .
Enzyme-linked immunosorbent assays (ELISAs). Serum levels of osteocalcin (Biomedical Technologies), TRAP-5b (Immunodiagnostic Systems), and C-propeptide of type I collagen (CTX-I) (Immunodiagnostic Systems) were determined by ELISA.
Colony-forming unit (CFU) assays. Total bone marrow was flushed from the femurs. Thereafter, red blood cells were lysed and 2 3 10 6 cells/well were plated in medium containing a-minimum essential medium (a-MEM) without ascorbic acid, 20% fetal bovine serum (FBS), and penicillin/streptomycin. After 2 days, cells were washed and exposed to osteoblast differentiation medium (50 mg/ml ascorbic acid and 10 mM b-glycerophosphate) for 14 days. Colony formation was assessed by staining the cells with alkaline phosphatase (Sigma).
Calvarial osteoblast cultures. Primary osteoblasts were isolated from the calvariae of C57BL/6 mouse pups (Charles River), and 8 3 10 4 cells/well were cultured in a-MEM supplemented with 10% FBS and treated with 50 mg/ml ascorbic acid and 10 mM b-glycerophosphate. On day 4, the cells were transfected with 1 mg/ml poly(dA-dT) using Lipofectamine 2000 (Invitrogen). RNA was isolated 5 days after transfection and subjected to quantitative polymerase chain reaction (qPCR).
Analysis of gene expression by qPCR. In qPCR analyses, 500 ng of total RNA was amplified. Gene expression was normalized to the values for the HMBS housekeeping gene. Primers were obtained from Qiagen. Data are expressed as the fold increase in gene expression compared with the normalized values in Lipofectamine controls, calculated using the 2 2DDCt method. Osteoclast assays. Experiments were performed in a-MEM containing 10% FBS and penicillin/streptomycin. Cells were flushed from the bone marrow and differentiated in 40 ng/ ml macrophage colony-stimulating factor (M-CSF) (R&D Systems) for 4 days. For differentiation, precursors were seeded at a density of 6,000 cells/well and differentiated in medium containing 20 ng/ml M-CSF and 10 ng/ml RANKL (R&D Systems) for 5 days. Half of the medium was replaced with fresh medium and cytokines on day 3. On day 5, cells were fixed and stained with TRAP to identify osteoclasts (Sigma). TRAP-stained osteoclasts with 3-10 nuclei were counted.
Precursors were also seeded at a density of 40,000 cells/well on hydroxyapatite-coated plates (Corning) and differentiated in a-MEM containing 40 ng/ml M-CSF and 20 ng/ ml RANKL for 10 days. Half of the medium was replaced with fresh medium and cytokines every 2 days. Cells were removed with 10% bleach. Wells were rinsed and scanned on a flatbed scanner (Microtek 9800 XL). The percentage of resorbed area was determined using NIH ImageJ software.
Radiography. Organs were radiographically imaged for 1 second at 35 kV using a Faxitron MX-20 machine.
NanoString spectrophotometry. Total RNA was isolated (RNeasy kit; Qiagen) and quantitated using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific). Subsequently, 100 ng of RNA was hybridized and quantified with a NanoString nCounter analysis system (NanoString Technologies). Gene expression data were normalized to the values in internal positive and negative control data sets and to the values for 3 housekeeping genes (GAPDH, GUSB, and HPRT1). All values were scaled using a log 2 (X2min[X]11) function, and a heatmap was generated using open-source R-based software at the University of Massachusetts Medical School.
Gene array. Total RNA was purified from the spleens using the RNeasy kit (Qiagen), and complementary DNA was generated from 200 ng of total RNA using a SensationPlus FFPE Amplification and WT labeling kit (Affymetrix). Samples were run on Affymetrix GeneChip Mouse Transcriptome Arrays (version 1.0), and quality control was performed using an Expression Console. Expression values were normalized with robust multiarray averaging, and the P values for the detection levels of each probe set were determined with the DABG (detectable above background) algorithm. Average values for biologic replicates, fold change values, and P values between groups (by analysis of variance [ANOVA]) were calculated using the transcriptome analysis console (Affymetrix). Differential expression of messenger RNA (mRNA) was identified as mRNA expression values that showed a significant change (P , 0.05 by ANOVA) of at least 1.5 fold over controls. All values were scaled using a log 2 (X2 min[X]11) function, and a heatmap was generated using opensource R-based software.
Statistical analysis. Statistical significance was analyzed with the Student's unpaired, 2-tailed t-test or ANOVA for multiple comparisons. Data are presented as the mean 6 SEM. P values less than 0.05 were considered significant.
RESULTS
Promotion of trabecular bone formation in mice with DNase II deficiency. As reported previously (17) , DNase II 2/2 /IFNAR 2/2 DKO mice develop a distal polyarthritis accompanied by bone erosion, resulting from the local expression of proinflammatory cytokines. We confirmed the presence of synovitis, pannus formation, and osteoclast-mediated articular erosion in the distal joints of DKO mice, and the absence of these findings in Het littermate controls ( Figure 1A ). Thus, in the joint microenvironment, typical osteoclast-mediated bone loss occurs.
However, despite the findings of local and systemic production of TNF, IL-1b, and IL-6 (which promote osteoclastogenesis), there was a surprising and significant accrual of trabecular bone in the tibiae adjacent to the inflamed ankle joints of DKO mice as compared with Het control mice ( Figure 1B ). This trabecular bone formation occurred despite the presence of an increased number of TRAP-expressing osteoclasts in DKO mice ( Figure 1B) , and was preceded by a marrow infiltrate that we have previously shown to be dependent on the expression of both the STING and endosomal TLR pathways (32) .
To quantitate bone accrual in the long bones, we analyzed the femurs of female DKO mice and Het control mice by micro-CT. As expected, Het control mice lose trabecular bone over time, due to aging as well as to the absence of type I IFN signaling, which promotes osteoclastogenesis and bone loss (29) . In contrast, arthritic DKO mice (that are also deficient in type I IFN signaling) demonstrated, paradoxically, a dramatic accrual of trabecular bone that appeared by age 5-6 months and progressed over time, such that by age 16 months, the marrow cavity was largely replaced by bone ( Figure 1C) .
Micro-CT analyses of the femurs from female mice confirmed a significant increase in trabecular bone volume/ total volume (BV/TV), trabecular bone surface, and trabecular connectivity density in 10-month-old DKO mice compared to controls ( Figure 1D ). Further analysis revealed a trend toward a decrease in cortical BV/TV and a significant decrease in cortical thickness in DKO mice compared to Het control mice (see Supplementary Figure 1 , available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.39863/abstract), thus demonstrating a loss of cortical bone over time in female DKO mice compared to Het controls. This loss may result from the accrual of trabecular bone, which provides mechanical support and reduces the load on cortical bone, or alternatively may be the result of a differential effect on bone cells in trabecular bone versus cortical bone.
The trabecular bone phenotype was more dramatic in female DKO mice. However, micro-CT analyses of the femurs from male DKO mice revealed a similar phenotype, with a trend toward increased trabecular bone surface and trabecular connectivity density as well as a significant loss of cortical bone compared with controls (see Supplementary Figure 2 , http://onlinelibrary.wiley.com/doi/10.1002/ art.39863/abstract). Thus, despite the expression of proinflammatory cytokines, the effects of aging on bone, and the lack of type I IFN signaling, all of which would be predicted to result in bone loss, mice with DNase II deficiency develop accrual of trabecular bone in the long bones over time.
Presence of bone accrual accompanied by an increase in osteoblast number and function. To determine the mechanism, parameters related to osteoblast and osteoclast number and function were examined. Static histomorphometric measurements of trabecular bone in the femurs from 10-month-old female mice showed a marked increase in osteoblasts (measured as ObS) and production of osteoid (measured as osteoid area [OAr]) in DKO mice compared with controls ( Figure 2A ). The ratios of ObS to bone surface and OAr to bone area were not significantly increased in DKO mice compared with controls, demonstrating that the numbers of osteoblasts were appropriate for the amount of bone produced (Figure 2A ). A significant increase in bone surface covered by osteoclasts (measured as OcS) was also observed in DKO mice compared with controls, demonstrating that a concomitant increase in osteoclast number occurred in DKO mice ( Figure 2B ). Again, similar ratios of OcS to bone surface were observed between Het mice and DKO mice, suggesting that the number of osteoclasts lining bone is the expected number for the bone present. In this model, the rapid deposition of woven bone precluded any attempts to dynamically measure the bone formation rates. , and OAr to bone area (BAr) (A), as well as osteoclast surface (OcS) and OcS to BS (B). C, Representative images from osteoblast colony-forming unit assays of the femoral bone marrow of 2.5-month-old male mice (n 5 5 mice/genotype). Colonies were stained with alkaline phosphatase (pink). D and E, Serum bone turnover markers in 10-month-old female mice (n 5 6-12 mice/genotype), including osteocalcin (D) and C-propeptide of type I collagen (CTX-I) and Trap5b (E). F, Number of TRAP1 cells in differentiation cultures of osteoclasts from 2.5-month-old male mice (n 5 3 mice/ genotype). G, Images of bone resorption measured on hydroxyapatite-coated plates (left) and percentage of hydroxyapatite area resorbed by osteoclasts from 2.5-month-old female and male mice (right) (n 5 6-7 mice/genotype). Symbols represent individual mice; bars show the mean 6 SEM. * 5 P , 0.05; ** 5 P , 0.01; *** 5 P , 0.001. See Figure 1 for other definitions. Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39863/abstract.
BAUM ET AL
To determine whether this bone phenotype is a result of increased osteoblast number, CFU assays were performed. Cells from the bone marrow of DKO mice demonstrated an increased number of colonies compared with controls, consistent with an increased number of mesenchymal precursor cells in the marrow ( Figure 2C ). Analysis of serum markers of bone turnover, including osteocalcin (indicative of bone formation), CTX-I (indicative of bone resorption), and Trap5b (indicative of osteoclast numbers), in 10-monthold female mice demonstrated that serum levels of osteocalcin trended higher in DKO mice compared with controls ( Figure 2D ), consistent with an increase in osteoblast activity. Levels of CTX-I and Trap5b were also significantly elevated in the serum of DKO mice compared with controls ( Figure 2E ), indicative of increased osteoclast activity and number.
To determine whether there is an intrinsic alteration in either the differentiation or function of osteoclasts that could be contributing to trabecular bone accrual, osteoclast differentiation and resorption assays were performed. These studies showed a trend, albeit not significant, toward increased osteoclast differentiation (measured with TRAP staining) in DKO mice compared with controls ( Figure 2F ), and showed no significant difference in bone resorption on hydroxyapatite-coated plates ( Figure 2G ).
Overall, these data suggest that the trabecular bone accrual in DKO mice results from an increase in osteoblast number, with an accompanying increase in osteoclast number. The balance between osteoblast and osteoclast activity over time thus appears to skew in favor of bone formation, and likely does not result from a decrease in osteoclast number or function, although the contribution of abnormal osteoclast-mediated bone resorption in vivo cannot be completely excluded.
Ectopic bone formation in DKO mouse spleens with aging. Imaging of 10-month-old female mice was performed to evaluate the entire skeleton. Unexpectedly, radiographic images revealed multiple calcified nodules in the spleens of DKO mice. Previous studies have shown that splenic enlargement occurs in DKO mice as compared with controls (17) . Radiographic imaging showed evidence of calcified nodules in the spleens of DKO mice, measuring up to 3 mm ( Figures 3A and B) . Histologic staining of samples from DKO mice demonstrated woven bone within splenic white pulp ( Figure 3C ), with osteoblasts ( Figure 3D ) and osteoclasts ( Figure 3E ) lining the surface of the bone. Additional stains showed that the bone was mineralized ( Figure 3F ), and robust osteoid production by osteoblasts was present at bone surfaces ( Figure 3G) . Analysis of the spleens from younger mice revealed that ectopic bone formation began at ;9 months of age in female mice and accrued over time (data not shown). Bone was not identified in the lymph nodes, liver, kidney, heart, intestine, or brain ( Figure  3H ), revealing that ectopic bone formation is unique to the spleen. Although many mouse models of autoimmunity do show splenic enlargement, the presence of ectopic bone is extremely rare (33) and suggests that osteoblasts are generated from mesenchymal precursor cells recruited to the spleen or present locally within the spleens of DKO mice.
To further explore these mechanisms, we utilized a customized NanoString code set containing 150 genes involved in innate immune and bone pathways. Analysis of gene expression in the mouse spleens revealed significant up-regulation of genes associated with bone resorption and formation in DKO mice compared with controls, and confirmed the spleen as a site of active bone formation ( Figure  3I ). The Col1A1 gene, which produces a component of type I collagen, a major constituent of bone, was highly upregulated in DKO mice compared with controls, as were the Bglap and Spp1 genes encoding osteocalcin and osteopontin, respectively, both being noncollagenous proteins found in bone. Moreover, genes encoding alkaline phosphatase, as well as the Dmp1 gene, a critical factor for bone mineralization produced by osteocytes and other cell types, were also up-regulated in DKO mouse spleens compared with controls. Up-regulation of the matrix metalloproteinase genes Mmp9 and Mmp13 reflect remodeling of the bone extracellular matrix. Additionally, the CTSK and ACP5 genes, encoding cathepsin K and Trap5b, respectively, were also significantly up-regulated in DKO compared with Het mouse spleens, a finding consistent with the enhanced osteoclast numbers in DKO mice.
Histologic analysis strongly suggested that the process of bone formation in DKO mice is similar in the long bones and spleen ( Figure 3J ), with lack of evidence of endochondral ossification at either site. Rather, the production of organic bone matrix, with subsequent mineralization of that matrix, was noted at both sites ( Figure 3J ). In DKO mice, the long bones and spleen are sites of erythropoiesis (17, 24) . To determine whether bone accrual was present in bones in which erythropoiesis typically does not occur in mice, such as the vertebrae (34), vertebral bodies were subjected to micro-CT analysis, and the results revealed a significant decrease in the BV/TV, trabecular surface, and trabecular connectivity density in DKO mice compared with controls (see Supplementary Figure 3 , http://onlinelibrary.wiley.com/doi/10.1002/art.39863/ abstract). These data suggest that local factors that promote the differentiation of mesenchymal precursor cells to osteoblasts may be released at sites of erythropoiesis (e.g., the long bones and spleen) (17, 35) .
Promotion of enhanced osteoblast differentiation and function in the spleens of mice with DNase II deficiency. The findings with regard to bone formation in the spleens of DKO mice provide additional evidence that bone accrual in this model is driven by the excessive differentiation and activity of osteoblasts, leading to the production and mineralization of bone matrix. This could result from either an increase in the number of Figure 3 . Ectopic bone formation in DKO mouse spleens. A, Representative images (top) and radiographs (bottom) of the spleens of 10-month-old female mice (n 5 6 mice/genotype). B, Islands of bone removed from 10-month-old female DKO mouse spleens. C-G, Representative images of histologic staining performed on DKO mouse spleen sections from 10-month-old female mice, including H&E-stained sections showing bone formation in white pulp (arrows identify osteoblasts lining the surface of bone) (C and D), TRAP-stained osteoclasts (arrows) (E), von Kossa's/fast green stains (black) showing mineralized bone (arrow) (F), and Goldner's trichrome stain (dark pink) demonstrating osteoid production (arrows) (G). Original magnification 3 4 in C; 3 20 in D-G. H, Representative radiographic images of the organs of 22-month-old female mice (n 5 3 mice/genotype). I, Heatmap showing NanoString mRNA profiling of key bone remodeling genes in 10-month-old female mouse spleens (n 5 3 mice/genotype). Left, The mean intensities of gene expression were transformed by a log 2 function. Right, Fold change in gene expression (with corresponding P values) was determined in DKO mice relative to Het control mice. J, Representative H&E-stained images of bone formation in DKO mouse spleens and tibiae. Arrows indicate fibrous tissue representing early bone matrix that may become mineralized. See Figure 1 for definitions. mesenchymal osteoblast precursors or an enhancement of osteoblast differentiation due to DNA accumulation within the cytosol of mesenchymal precursor cells themselves. To test the effect of DNA on differentiation, calvarial osteoblasts were transfected with the dsDNA mimetic poly(dA-dT), and differentiation was determined using staining for alkaline phosphatase. Interestingly, transfection of calvarial osteoblasts with DNA upregulated the expression of p204, a cytosolic DNA sensor previously shown to also act as a transcriptional coactivator of bone formation (36) (37) (38) . However, the levels of alkaline phosphatase were significantly reduced in cells transfected with dsDNA (Figure 4) , suggesting that accumulation of dsDNA in osteoblast precursors inhibits, rather than promotes, differentiation. These results support an alternative hypothesis, that the number of osteoblast precursor cells is increased and/or that extrinsic factors expressed by other cell types drive the differentiation of mesenchymal precursors to the osteoblast lineage in this model.
To identify factors promoting osteoblast differentiation and bone formation, gene expression in 10-monthold DKO mouse spleens was examined by array analysis. The results revealed up-regulated expression of numerous genes regulating osteoblast differentiation and bone formation ( Figure 5 ). Among the most highly regulated osteoblast-related genes in the whole spleen were 2 transforming growth factor b (TGFb) genes (Tgfbi and Tgfbr1). TGFb signaling promotes the recruitment of osteoblast progenitors (39) . Moreover, the gene encoding the bone morphogenetic protein (BMP)-signaling transducer Smad1, which regulates expression of the osteoblastspecific transcription factors Runx2 and Osterix (39) , as well as the Runx2 gene itself, were up-regulated in DKO mice compared with controls. The Bmp1 gene, which encodes a type I collagen C-propeptidase required for mature collagen maturation in bone, was also upregulated. We did not detect up-regulation of other BMP receptor ligands known to promote osteoblast differentiation, including BMPs 2, 4, 6, or 7. In addition, we found an up-regulation of the Gdf3 gene, a member of the TGFb superfamily and an inhibitor of BMP signaling, which would be expected to inhibit bone formation and may represent a compensatory mechanism to inhibit local osteoblast differentiation.
Regulation of several other genes supports the interpretation of splenic tissue as a site at which mesenchymal precursor cells are differentiating to osteoblasts. The Vdr gene, encoding the vitamin D receptor, was upregulated in DKO mice compared with Het control mice. This receptor induces expression of factors that enhance osteoblast differentiation and inhibit apoptosis of osteoblasts. Recently, transgenic overexpression of Vdr in mature osteoblasts was shown to increase trabecular BV (40) . The Serpinf1 gene, encoding pigment epitheliumderived factor (PEDF), was also up-regulated in DKO mouse spleens. PEDF modulates the differentiation of human and murine mesenchymal stem cells by promoting osteogenesis and inhibiting adipogenesis (41) . In addition, the Serpinh1 gene, encoding heat-shock protein 47 (Hsp47), was up-regulated in DKO mouse spleens compared with controls. Hsp47 is localized in the endoplasmic reticulum and acts as a molecular chaperone for the maturation of collagen (42) . Finally, expression of the Pth1r gene, encoding the parathyroid hormone (PTH) receptor, was up-regulated in DKO mice, which would promote osteoblast differentiation in the presence of PTH (43) .
Regulation of bone formation by the STING pathway. We then examined the role of the STING pathway in bone formation in DKO mice. In this model, cytosolic sensors detect host DNA and signal through STING to induce type I IFN, TNF, IL-6, and IL-1b. We and others have previously shown that arthritis in DKO mice is abrogated by deletion of STING in mice triple deficient in STING, DNase II, and IFNAR (STKO mice) and in STING 2/2 /DNase II 2/2 double-deficient mice (4, 18) . In order to determine whether the osteogenic factors identified in DKO mice were up-regulated in a STING-dependent manner, we performed gene array analysis in the spleens of STKO mice. Expression of pro-osteogenic genes, including Tgfbi, Tgfbr1, Smad1, Runx2, Vdr, Serpinf1, and Pth1r, was not induced in mice in the setting of STING deficiency ( Figure 5) .
Importantly, in vivo, STING deficiency in DKO mice ameliorated not only arthritis, but also bone accrual in both the long bones ( Figure 6A ) and the spleens ( Figure 6B ). The trabecular BV/TV and trabecular bone surface were dramatically decreased in STKO mice compared with DKO mice. Moreover, the expression of genes associated with osteoblast activity (Col1a1, Spp1, Col1a2, Bglap, Omd, Alpl, Ibsp, Phex, Dmp1), matrix bone remodeling (Mmp13), and osteoclasts (CTSK, ACP5) was Figure 6 . Requirement of the STING pathway in bone accrual in DKO mice. A, Sagittal and transverse micro-computed tomography (micro-CT) images of the femurs of Het, DKO, and STKO mice (top), and quantitation of micro-CT data for trabecular (Trab.) bone volume/total volume (BV/TV) and trabecular bone surface in 10-month-old female mice (bottom) (n 5 4-7 mice/genotype) (values for the Het and DKO mice are the same as those shown in Figure 1D ). Symbols represent individual mice; bars show the mean 6 SEM. * 5 P , 0.05; ** 5 P , 0.01; *** 5 P , 0.001. B, Representative images and radiographs of the spleens of 10-month-old female mice (n 5 4-6 mice/genotype). C, Left, The heatmap shows the mean intensities of gene expression in gene arrays of the spleens of 10-month-old mice (n 5 3-4 mice/genotype). Signals were transformed by a log 2 function. Right, The fold change in gene expression (with corresponding P values) was determined in DKO mice relative to Het control mice and in STKO mice relative to DKO mice. See Figure 5 for other definitions.
significantly decreased in STKO mouse spleens compared with DKO mouse spleens ( Figure 6C ), demonstrating that local bone formation in the setting of DNA accrual is dependent on an intact STING pathway. These results reveal a novel mechanism of aberrant bone formation in this mouse model of arthritis.
DISCUSSION
In this study, we demonstrate a novel pathway regulating bone and show that accrual of undegraded DNA and the resulting inflammatory response promotes the activation of cytosolic nucleic acid sensors, leading to trabecular bone accrual in the long bones and spleen of mice. This occurs despite the presence of arthritis and osteoclast-mediated articular bone erosion, and despite the production of proinflammatory cytokines that promote bone loss. Bone formation results from an increase in osteoblast number and function, and the bone phenotype manifests late, beginning at ;5-6 months of age, in the long bones of mice, while bone formation in the spleen appears by age 9-10 months. This late manifestation can likely be attributed to the requirement for accrual of DNA over time, as well as to the time required for the enhancement of bone formation over bone resorption to ultimately favor bone accrual. DKO mice develop splenomegaly associated with excessive numbers of Ter1191 cells by an early age. Thus, both the long bones and spleen are sites of erythropoiesis and the chronic accrual of extruded, undegraded nuclei from reticulocytes. The inability, in DKO mice, to degrade DNA eventually leads to infiltration of DNA into cytosolic compartments and activation of cytosolic DNA sensors that converge on STING. In addition, the ensuing inflammation and cell death most likely lead to the release of ligands that can engage endosomal TLRs, which have been implicated in both autoantibody formation and splenomegaly in these mice (4, 19, 32) . These pathways may contribute to bone formation in this model as well.
Affymetrix data from spleen samples demonstrated a major drive toward osteogenesis and identified a number of up-regulated osteogenic factors at this site of extramedullary erythropoiesis. Among the most highly regulated were the genes in the TGFb family. Although the role of TGFb signaling in bone is complex, TGFb isoforms and their receptors (including the TGFb type I receptor [TGFbRI] ) are known to expand the pool of mesenchymal osteoblast progenitor cells (44) . Moreover, mice with tissue-specific removal of TGFbRI show reduced trabecular bone in the long bones and decreased proliferation and differentiation of osteoblasts (45) . Additionally, the genes encoding the osteogenic BMP-signaling transducer Smad1 and the osteoblast-specific transcription factor Runx2 were up-regulated in DKO mice compared to controls.
Bone formation in the long bones and spleen appears to be regulated by similar mechanisms, given the gene expression profiles and histologic features at these sites. However, bone formation in the spleen requires the presence of a population of mesenchymal osteoblast precursor cells that either are recruited to splenic tissue or are resident within this site. One possible mesenchymal precursor with osteogenic potential is the pericyte. Microvascular pericytes have long been known to serve as a reservoir for multiple cell lineages in the joints, including osteoblasts (46) . It has been shown that vascular pericytes implanted into athymic mice reproducibly form cartilage and bone. Furthermore, these cells can secrete components of bone matrix associated with initiation of mineralization and nucleation of hydroxyapatite (46) . Bone forms in DKO mouse spleens in a process similar to what is seen in implanted vascular pericyte cultures. Pericytes may arise from CD34-expressing progenitor cells within the vessel walls (47) , and it is of interest that bone in the spleen forms in regions of white pulp, areas rich in vasculature.
These findings may also be relevant to several human diseases in which abnormal bone formation occurs in soft tissues. Heterotopic ossification (HO) is a debilitating condition associated with formation of lamellar bone in extraskeletal sites. The etiology of acquired HO is unknown, although heterotopic lesions occur following soft tissue trauma and viral infections (48) (49) (50) . These triggers precede ectopic bone formation and strongly implicate a role for innate immune pathways of inflammation in the pathogenesis of HO. It is possible that viral DNA or DNA released from damaged cells may overwhelm the activity of DNase II, triggering the activation of innate immune DNA sensors. Further investigation into these mechanisms may elucidate novel pathways that could be targeted for the prevention and treatment of bone abnormalities in human autoimmune diseases and in heterotopic bone formation.
